Analysts at Oppenheimer initiated coverage on Rockwell Medical Inc RMTI with a Outperform rating.
The target price for Rockwell Medical is set to $24.
Rockwell Medical shares have dropped 5.37% over the past 52 weeks, while the S&P 500 index has gained 8.99% in the same period.
Rockwell Medical's shares rose 6.73% to $10.15 in pre-market trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in